1. Introduction
When it comes to the issue of apportioning damages in patent
infringement cases, there is a major difference between the Chinese
and U.S. patent law regimes. In the U.S., apportionment can be done
at both the royalty base (through “smallest saleable patent
practicing unit” , SSPPU) and royalty rate (i.e., a portion
of the royalty base) level to determine the value of patented
technology. In China, however, apportionment can be only done at
the royalty rate level and the entire market value of the accused
product is always selected as the royalty base. As the SSPPU
doctrine has not yet been recognized in China, apportionment is
conducted by multiplying a percentage and the selling price of the
entire accused product. China's current judicial standards
for determining an appropriate royalty rate/percentage are vague
and incongruous. Courts have broad discretion to decide a royalty
rate ranging from 1% to 100%. As a result, the patent damages in
many